Board Meeting Details

The Board of Directors meeting was convened and held at the company's registered office in Delhi on May 29, 2026, from 5:00 PM to 7:00 PM.

Financial Results Approval

The Board approved:

1. Audited Standalone Financial Results for quarter and year ended March 31, 2026

2. Audited Standalone Financial Statements for year ended March 31, 2026

Financial Performance Highlights (₹ in Lacs)

Quarter Ended March 31, 2026 (Audited):

  • Revenue from Operations: ₹0
  • Total Income: ₹0
  • Total Expenses: ₹4,986.14
  • Profit before tax: (₹4,986.14)
  • Net Profit/(Loss): (₹4,986.14)
  • Basic EPS: (₹0.40)
  • Diluted EPS: (₹0.40)

Year Ended March 31, 2026 (Audited):

  • Revenue from Operations: ₹36,553.83
  • Other Income: ₹146.43
  • Total Income: ₹36,700.26
  • Purchases of stock-in-trade: ₹32,236.71
  • Employee benefit expense: ₹10.36
  • Depreciation & Amortization: ₹1.91
  • Other expenses: ₹5,000.29
  • Total Expenses: ₹37,249.27
  • Profit before tax: (₹549.01)
  • Tax Expense: ₹0
  • Net Profit/(Loss): (₹549.01)
  • Basic EPS: (₹0.04)
  • Diluted EPS: (₹0.04)
  • Paid-up equity share capital: ₹12,359.40

Comparative Figures (Year Ended March 31, 2025):

  • Revenue from Operations: ₹2,455.00
  • Total Income: ₹2,645.99
  • Net Profit: ₹217.01
  • Basic EPS: ₹0.36

Balance Sheet Position as at March 31, 2026 (₹ in Lacs)

Assets:

  • Property Plant and Equipment: ₹1.11
  • Other Intangible assets: ₹128.74
  • Financial Assets: ₹15,126.13
  • Investments: ₹8.02
  • Inventories: ₹14,352.36
  • Trade receivables: ₹21,335.94
  • Cash and cash equivalents: ₹57.62
  • Other Financial Assets: ₹0
  • Other current assets: ₹9.02
  • Total Assets: ₹51,018.95

Liabilities and Equity:

  • Equity Share capital: ₹12,359.40
  • Other Equity: (₹2,657.37)
  • Trade Payables: ₹19,946.50
  • Micro enterprises and small enterprises: ₹0
  • Other than micro and small enterprises: ₹19,946.50
  • Other Financial Liabilities: ₹21,307.72
  • Other current liabilities: ₹1.68
  • Current Tax Liabilities: ₹61.00
  • Total Liabilities: ₹41,276.90

Cash Flow Statement for Year Ended March 31, 2026 (₹ in Lacs)

  • Net Cash Flow from Operating Activities: ₹173.53
  • Net Cash Flow from Investing Activities: (₹128.74)
  • Net Cash Flow from Financing Activities: ₹0
  • Net Increase in Cash & Cash Equivalents: ₹44.79
  • Opening Cash & Cash Equivalents: ₹12.83
  • Closing Cash & Cash Equivalents: ₹57.62

Segment Reporting

The company operates primarily in the Agriculture segment, with no revenue from Drugs and Pharmaceuticals segment:

  • Agriculture Segment Revenue FY26: ₹36,700.26
  • Agriculture Segment PBT FY26: (₹549.01)
  • Agriculture Segment Assets FY26: ₹51,018.95
  • Agriculture Segment Liabilities FY26: ₹49,893.83